Investor relations

IR Contact

Investor related questions may be directed to Cereno Scientific’s CFO Daniel Brodén.

Email: daniel.broden@cerenoscientific.com

Phone: +46 768 66 77 87

Press & news

10 Dec

News

Cereno Scientific strengthens its pipeline for the second time this year Cereno Scientific is developing a platform of cardiovascular therapies in...

10 Dec

Press release

Cereno Scientific broadens its pipeline – signs agreement on acquisition of compound in preclinical phase Cereno Scientific announced today that the company has signed an...

20 Nov

News

Approved study and prestigious meetings in fibrosis put Cereno Scientific in the limelight Yesterday, news came that Cereno Scientific had received approval for...

Calendar

Nordic-American Life Science Conference 2019-12-04 - 2019-12-05

16th Global Cardiovascular Clinical Trialists Forum 2019-12-05 - 2019-12-07

LeadingBiotech: East/West CEO 2020-01-11 - 2020-01-12

Biotech Showcase™ 2020 2020-01-13 - 2020-01-15

More about us...

Subscribe for corporate news

Follow us on LinkedIn

Follow us on Twitter

Privacy policy

We are proud supporters of World Thrombosis Day. Read more